High-purity, plasma-derived, pasteurized Factor VIII concentrates in the treatment of patients with haemophilia A: update of a long-term pharmacovigilance study

被引：0
|
作者：
Klamroth, Robert [1 ]
Holzhauer, Susanne [2 ]
Heller, Christine [3 ]
Sommerer, Patrick [4 ]
Kurnik, Karin [5 ]
机构：
[1] Vivantes Klinikum Friedrichshain, Berlin, Germany
[2] Univ Hosp Charite, Berlin, Germany
[3] Goethe Univ Frankfurt, Comprehens Care Ctr Thrombosis & Haemostasis, D-60054 Frankfurt, Germany
[4] CSL Behring GmbH, Marburg, Germany
[5] Univ Hosp Munich, Dr v Haunersches Childrens Hosp, Munich, Germany
来源：
HAEMOPHILIA | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [1] High-purity, plasma-derived, pasteurized factor VIII concentrate in the treatment of patients with hemophilia A: Update of a long-term pharmacovigilance
    Klamroth, R.
    Holzhauer, S.
    Juers, M.
    Kurnik, K.
    HAEMOPHILIA, 2012, 18 : 150 - 150
  • [2] High-purity, plasma-derived, pasteurised factor VIII concentrate in the treatment of patients with haemophilia A: update of a long-term observational study
    Klamroth, R.
    Niekrens, C.
    Holzhauer, S.
    Fischer, R.
    Heller, C.
    Sommerer, P.
    Kurnik, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 822 - 822
  • [3] Long-term efficacy and safety of a pasteurized, plasma-derived factor VIII concentrate (Beriate® P) in patients with haemophilia A
    Klamroth, Robert
    Gottstein, Saskia
    Orlovic, Marija
    Heinrichs, Christl
    THROMBOSIS RESEARCH, 2014, 134 : S38 - S42
  • [4] Plasma derived factor VIII in the treatment of patients with hemophilia A: update of a long-term pharmacovigilance
    Klamroth, R.
    Zimmermann, R.
    Schuetz, B.
    Zacharias, C.
    Broder, M.
    Kurnik, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1129 - 1129
  • [5] Plasma derived factor viii in the treatment of patients with hemophilia a: update of a long-term pharmacovigilance
    Klamroth, R.
    Zimmermann, R.
    Holzhauer, S.
    Stockschlaeder, M.
    Zacharias, C.
    Kurnik, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 117 - 117
  • [6] Plasma-derived versus recombinant factor VIII concentrates for the treatment of haemophilia A: plasma-derived is better
    Mannucci, Pier Mannuccio
    BLOOD TRANSFUSION, 2010, 8 (04) : 288 - 291
  • [7] Plasma-derived, purified, pasteurised von Willebrand factor/factor VIII concentrate in the treatment of patients with von Willebrand disease and haemophilia a: update of a long-term observational study
    Wermes, C.
    Holzhauer, S.
    Halimeh, S.
    Kemkes-Matthes, B.
    Sommerer, P.
    Wieland, I
    Krause, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 497 - 497
  • [8] Plasma-derived versus recombinant Factor VIII concentrates for the treatment of haemophilia A: recombinant is better
    Franchini, Massimo
    BLOOD TRANSFUSION, 2010, 8 (04) : 292 - 296
  • [9] Pasteurized, monoclonal antibody factor VIII concentrate: establishing a new standard for purity and viral safety of plasma-derived concentrates
    Goldsmith, JC
    BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 (02) : 203 - 215
  • [10] PASTEURIZED AND HIGH-PURITY FACTOR-VIII IN THE TREATMENT OF VONWILLEBRANDS DISEASE
    HANNA, WT
    BONA, RD
    RICKLES, FR
    ZIMMERMAN, CE
    TRANSFUSION, 1991, 31 (04) : 375 - 375
12345